HLA-DRB1 and myeloid sarcoma: Specifically, acetylation of histone H3 within the DRB1*15:01 promoter region was associated with increased expression of the gene in MS patients, suggesting that epigenetic modifications of histones may also play a role in regulating DRB1*15:01 expression in MS.